Details

Project TitleSepsis Treatment Inactivates Endotoxins Using Molecules Derived From Chitosan Derivative
Track Code65894
Websitehttp://otc-prf.org/
Short Description

Yoon Yeo

Yeo Lab

Purdue Industrial and Physical Pharmacy

Abstract
 
Tagsbiomedical engineering, green technology, Medical/Health, sepsis, Treatment Methods, Endotoxins, clean water, water, antimicrobials
 
Posted DateJul 12, 2013 12:28 PM

Researcher

Name
Yoon Yeo
Peisheng Xu
Gaurav Bajaj

Sepsis Treatment Inactivates Endotoxins Using Molecules Derived From Chitosan Derivative

Background

Septicemia refers to the presence of pathogens in the bloodstream that leads to sepsis, a potentially life-threatening medical condition characterized by whole-body inflammation and the presence of infection. When microbes infect the blood, skin, lungs or other tissues, the body's immune system generates an inflammatory response in an attempt to fight the infection. The body's immune response to the infection causes the characteristic symptoms of sepsis and can lead to organ failure. The current treatment for sepsis requires antibiotics, fluid drainage, blood transfusions, and dialysis. Since individual cases are caused by different microbes, the correct antibiotic must be chosen to treat the infection. This causes a delay in treatment, which leads to an increase in the mortality rate.

Technology Summary

Purdue University researchers have developed a novel treatment for septicemia involving molecules derived from chitosan. Chitosan is a linear carbohydrate with many commercial and biomedical uses. This treatment inactivates endotoxins, which are toxins associated with certain types of bacteria and stimulates cytokine release (part of the body's inflammatory response that causes swelling and high fever). This new chitosan shows many advantages over current IV treatments for septicemia. This technology can be used to filter endotoxins out of plasmid DNA samples and filter bacteria from water, making contaminated water samples safe to drink.

Advantages

  • Stronger affinity for inactivating endotoxins
  • Excellent biocompatibility upon injection 
  • Lower potential to cause hemolysis, complement activation, and inflammatory responses
  • Can filter endotoxins out of plasmid DNA samples and remove bacteria from water

Potential Applications

  • Medical/Health
  • Sepsis treatment
  • Contaminant removal from drinking water

Stage of Development

Proof of Concept

Web Links

For additional information, please contact otcip@prf.org.

Files

File Name Description
Patent Application Publication None Download

Intellectual Property

Patent Number Issue Date Type Country of Filing
None None Utility United States